OT2-06-02:趋化因子调节提高派姆单抗在转移性三阴性乳腺癌患者中的有效性

{"title":"OT2-06-02:趋化因子调节提高派姆单抗在转移性三阴性乳腺癌患者中的有效性","authors":"Y. Abdou, L. Williams, P. Kalinski, M. Opyrchal","doi":"10.1158/1538-7445.SABCS18-OT2-06-02","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19476,"journal":{"name":"Ongoing Clinical Trials","volume":"27 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract OT2-06-02: Chemokine modulation to enhance the effectiveness of pembrolizumab in patients with metastatic triple negative breast cancer\",\"authors\":\"Y. Abdou, L. Williams, P. Kalinski, M. Opyrchal\",\"doi\":\"10.1158/1538-7445.SABCS18-OT2-06-02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19476,\"journal\":{\"name\":\"Ongoing Clinical Trials\",\"volume\":\"27 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ongoing Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.SABCS18-OT2-06-02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ongoing Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.SABCS18-OT2-06-02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}